Celyad Oncology SA: Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Regulatory News: Celyad Oncology SA (Euronext Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric

Related Keywords

Mont Saint Guibert ,Waals Gewest ,Belgium ,New York ,United States ,Walloon Region ,Paris ,France General ,France ,Brussels ,Bruxelles Capitale ,Sara Zelkovic ,Filippo Petti ,Exchange Commission ,Communications Investor Relations ,Lifesci Advisors ,Fortress Investment Group ,Regulatory News ,Euronext Nasdaq ,Celyad Oncology ,Voting Rights ,Press Release ,Chief Executive Officer ,Private Securities Litigation Reform Act ,Annual Report ,Media Contacts ,Investor Relations Director ,Sci Advisors ,Celyad ,Ncology ,Transparency ,Notification ,Eceived ,Rom ,Fortress ,Investment ,Group ,Article ,007 ,